Nobilis SG 9R

Indications

• Fowl typhoid
• Salmonellosis in poultry

Dosage

Children: Refer to veterinary guidelines for treatment in juvenile birds, as dosage may vary based on age, weight, and specific veterinary recommendations.

Adults: Refer to veterinary guidelines and specific products for treatment dosage, as Gallinarum is primarily a pathogen and not a therapeutic agent.

Mechanism of action

Gallinarum exerts its pathogenic effects through various mechanisms, including the invasion of host intestinal epithelial cells, evasion of the host immune response, and the production of virulence factors. These factors contribute to inflammation, tissue damage, and systemic infection in susceptible hosts.

Pharmacodynamics

The pharmacodynamics of Gallinarum are characterized by its ability to proliferate within the host, leading to systemic disease. The bacterium induces an inflammatory response, which can result in clinical symptoms such as lethargy, decreased feed intake, and high mortality rates in affected poultry. The virulence of Gallinarum is closely associated with its genetic components that facilitate invasion and survival in the host.

Pharmacokinetics

As a bacterial pathogen, Gallinarum does not have pharmacokinetic properties in the traditional sense as drugs do. Instead, its lifecycle involves replication within the host and transmission through fecal-oral routes. It thrives in the digestive tract of birds, where it can persist and cause disease. Antibiotic treatment in infected poultry may influence the bacterial load and the duration of infection.

Pregnancy

Safety during pregnancy has not been established. Consult a healthcare provider before use.

Breast-feeding

It is not known if gallinarum is excreted in human milk. Exercise caution and consult a healthcare provider.

Storage

Store at room temperature, away from moisture and light.

Indications

• Induction of anesthesia
• Maintenance of anesthesia during surgery
• Sedation for procedures
• Pain management

Dosage

Children: Dosing in pediatric patients must be determined based on the specific agent and the child's age, weight, and clinical condition. Refer to BNF for Children for precise dosing recommendations.

Adults: Dosing varies widely based on the specific anaesthetic agent and the procedure being performed. Refer to specific guidelines or BNF for exact dosing information.

Mechanism of action

Least-acting anaesthetics primarily exert their effects by enhancing inhibitory neurotransmission, particularly through the modulation of gamma-aminobutyric acid (GABA) receptors. This results in increased chloride ion influx into neurons, leading to hyperpolarization and decreased neuronal excitability. Additionally, these agents may inhibit excitatory neurotransmitter pathways, contributing to their anesthetic effects.

Pharmacodynamics

The pharmacodynamics of least-acting anaesthetics involve a balance between sedation and analgesia, with the goal of achieving an appropriate depth of anesthesia for surgical procedures. The effects are dose-dependent, with lower doses providing sedation and higher doses leading to full anesthesia. The therapeutic window is critical, as excessive doses can lead to respiratory depression and cardiovascular instability.

Pharmacokinetics

Least-acting anaesthetics are generally characterized by rapid absorption and distribution, allowing for quick onset of action. They are metabolized primarily in the liver, with some agents undergoing hydrolysis in the plasma. The elimination half-life can vary significantly among different agents, influencing the duration of action. Factors such as age, liver function, and concurrent medications can affect the pharmacokinetics of these agents.

Pregnancy

Use during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Caution is advised; it is recommended to consult a healthcare provider before use.

Storage

Store in a cool, dry place, away from direct light and moisture.

Indications

• Measles
• Mumps
• Rubella
• Varicella (chickenpox)
• Yellow fever
• Rotavirus
• Intranasal influenza

Dosage

Children: Refer to the BNF for Children for specific dosing information based on age and vaccine type.

Adults: Refer to specific product guidelines for dosing information, as it can vary by vaccine type and brand.

Mechanism of action

Live vaccines work by introducing a weakened or attenuated form of a pathogen into the body. This stimulates the immune system to recognize and respond to the pathogen, leading to the production of antibodies and memory cells that provide long-term protection against future infections by the same pathogen.

Pharmacodynamics

The pharmacodynamics of live vaccines involve the activation of both humoral and cellular immunity. Following vaccination, the immune system generates a robust response, including the production of specific antibodies and the activation of T cells that can recognize and eliminate infected cells. This dual action helps establish long-term immunity.

Pharmacokinetics

The pharmacokinetics of live vaccines vary depending on the specific vaccine. Generally, the vaccine is administered via injection, allowing the live attenuated organisms to enter the bloodstream. The immune response typically begins within days and can last for years, depending on the vaccine. Live vaccines are usually stored under refrigeration to maintain their viability, and they should be administered within their expiration dates.

Interactions

• livevaccines + abrocitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + baricitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + filgotinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + dexrazoxane: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + iron chelators: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + ozanimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + ponesimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + siponimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + upadacitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + diroximelfumarate: Moderate (increases risk of generalised infection (possibly life-threatening))

Indications

• Infectious diseases caused by bacteria
• Viral infections
• Fungal infections
• Parasitic infections

Dosage

Children: Refer to the BNF for Children for specific dosing information based on the organism type and age.

Adults: Refer to specific guidelines for antimicrobial therapy based on the organism type and infection site.

Mechanism of action

The mechanism of action of organisms varies widely depending on the type. For example, bacteria can reproduce rapidly and may produce toxins that interfere with host cellular functions. Viruses invade host cells and hijack cellular machinery to replicate. Fungi can disrupt cell membranes and evade the immune response. Each organism has unique pathways for infection, propagation, and interaction with host defenses.

Pharmacodynamics

Pharmacodynamics of organisms relates to their growth, replication, and the effects they have on the host. Pathogenic bacteria can elicit immune responses leading to inflammation. Viruses often induce cellular apoptosis or necrosis, while fungi can cause damage through their metabolic byproducts. The interaction between the organism and the host's immune system is crucial in determining the severity of the disease.

Pharmacokinetics

Pharmacokinetics of organisms is not applicable as they do not have a pharmacokinetic profile like drugs. Instead, their behavior in the host can be characterized by their replication rate, survival in various environments, and the ability to develop resistance to antimicrobial agents. The distribution of organisms in the body, their elimination through immune responses, and their potential to establish reservoirs or persistence in host tissues are critical.

Indications

• Salmonellosis
• Gastroenteritis
• Typhoid fever
• Paratyphoid fever

Dosage

Children: Refer to appropriate guidelines based on the severity of the infection and local antimicrobial susceptibility patterns.

Adults: Refer to appropriate guidelines based on the severity of the infection and local antimicrobial susceptibility patterns.

Mechanism of action

Salmonella bacteria invade the intestinal mucosa and evade the host's immune response. They utilize a type III secretion system to inject virulence factors into host cells, facilitating their entry and promoting inflammation. This invasion disrupts normal intestinal function, leading to diarrhea, abdominal pain, and systemic symptoms.

Pharmacodynamics

The pathogenicity of Salmonella is largely attributed to its ability to adhere to and invade host epithelial cells, triggering an inflammatory response. The bacteria can survive and replicate within macrophages, allowing them to disseminate systemically. The inflammatory response contributes to the clinical manifestations of the infection, including fever and diarrhea.

Pharmacokinetics

Salmonella does not have pharmacokinetics as it is a bacterial pathogen rather than a drug. However, the course of infection can be influenced by host factors, such as immune response and the presence of underlying health conditions. Antibiotic treatment may alter the natural course of infection and influence the duration and severity of symptoms.

Adverse effects

• Diarrhea
• Fever
• Abdominal cramps
• Nausea
• Vomiting

Precautions

• Ensure proper food handling and hygiene practices to prevent infection.
• Use caution in immunocompromised patients who may be at higher risk for severe disease.

Pregnancy

Salmonella infections during pregnancy can lead to complications such as miscarriage or premature labor. Caution is advised.

Breast-feeding

Salmonella can be transmitted through contaminated breast milk, though this is rare. Mothers should be cautious about food hygiene.

Indications

• Bacterial infections
• Viral infections
• Epidemiological studies
• Antibiotic resistance monitoring

Dosage

Children: Refer to specific antimicrobial treatment guidelines based on the strain identified and the infection site.

Adults: Refer to specific antimicrobial treatment guidelines based on the strain identified and the infection site.

Mechanism of action

The mechanism of action for a strain depends on the type of microorganism it represents. For pathogenic bacteria, the strain may produce toxins, evade the host's immune response, or possess resistance mechanisms that allow it to survive in the presence of antibiotics. For viruses, strains may exhibit mutations that alter their ability to infect host cells or evade antiviral therapies.

Pharmacodynamics

Pharmacodynamics in the context of strains involves the interaction between the strain and the host's immune system, as well as the effects of specific antimicrobial agents on the strain. These interactions can influence the efficacy of treatments and the development of resistance.

Pharmacokinetics

Pharmacokinetics is not directly applicable to strains themselves but rather to the drugs used to treat infections caused by specific strains. Factors such as absorption, distribution, metabolism, and excretion of antimicrobial agents can vary depending on the strain's characteristics and the site of infection.

Pregnancy

There is limited information on the safety of strain in pregnancy. It is advisable to consult healthcare professionals for guidance.

Breast-feeding

Safety during breastfeeding is not well established. It is recommended to seek medical advice before use.

Storage

Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.